The Handling of Hazardous Drugs

Pharmacist CEU
notesMonograph
Contact Hours: 2.0 (0.2 CEUs)

Course Summary

Drugs used to treat cancer, some antiviral drugs, hormone agents, and bioengineered drugs, are dangerous to pharmacists and other healthcare workers because of their toxicity. Exposure to these hazardous drugs in the course of professional practice can injure the healthcare worker. Proper precautions and care are necessary to prevent these occupational injuries. Pharmacists and pharmacy staff can appreciate the importance of handling hazardous drugs properly through a brief review of the history of hazardous drugs and the development of guidelines for their proper handling.


Course Objectives

Review the latest regulations relating to the handling of hazardous drugs.

Identify the importance of regulations and standards in handling hazardous drugs for the safety of patients, pharmacy staff, and the environment.

Describe the complexity of the hazardous drug regulations for staff working in a hazardous compounding pharmacy or looking to start one.

Describe the procedures to follow in the event of exposure to hazardous drugs.


I. Introduction

II. History of Hazardous Drugs

III. Importance of HDs to Pharmacy Staff

IV. USP 800

1. Facilities and Engineering Controls
2. Receipt
3. Storage
4. Compounding
5. ISO Class 7 buffer room with ISO class 7 ante-room
6. Environmental Quality and Control
7. Personal Protective Equipment
8. Disposal of Used PPE
9. Hazard Communication Program
10. Personnel Training
11. Receiving
12. Labeling, Packaging, Transport, and Disposal
13. Dispensing Final Dosage Forms
14. Compounding
15. Deactivating, Decontaminating, Cleaning, and Disinfecting
16. Deactivation
17. Decontamination
18. Cleaning
19. Disinfection
20. Spill Control
21. Medical Surveillance
22. Follow-Up Plan
23. Clinical setting variation
24. Patient Counseling on the Handling of Hazardous Drugs

V. Summary

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in the development of this activity: Susan DePasquale, MSN, PMHNP-BC, and Steve Malen, PharmD. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.


Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

  • Target Audience: Pharmacist
  • Contact Hours: 2.0 (0.2 CEUs)
  • Activity Release Date: 12/10/2022
  • Activity Expiration Date: 12/10/2025
  • Activity Type: Knowledge
  • UAN: 0669-0000-22-076-H07-P
  • Topic: Compounding
  • CeBroker Number: 20-977778

Author:

Steve Malen, PharmD, MBA

AUTHOR BIO

VIEW PDF VIEW AS WEB PAGE

The logo for the Accreditation Council for Pharmacy Education (ACPE).

RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

‹‹ Back to Course List